John P Brancaccio's Net Worth
-$133 Thousand
Who is John P Brancaccio?
John P Brancaccio does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Tamir Biotechnology, Inc., Synergy Pharmaceuticals, Inc., Accustem Sciences Inc., Hepion Pharmaceuticals, Inc., Cardiff Oncology, Inc., OKYO Pharma Ltd, and CALLISTO PHARMACEUTICALS INC.
SEC CIK
John P Brancaccio's CIK is 0001276551
Past Insider Trading and Trends
2014 was John P Brancaccio's most active year for acquiring shares with 11 total transactions. John P Brancaccio's most active month to acquire stocks was the month of May. 2013 was John P Brancaccio's most active year for disposing of shares, totalling 43 transactions. John P Brancaccio's most active month to dispose stocks was the month of December. 2018 saw John P Brancaccio paying a total of $1,794,011.50 for 307,490 shares, this is the most they've acquired in one year. In 2016 John P Brancaccio cashed out on 5,036 shares for a total of $14,503.68, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Tamir Biotechnology, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 28
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
| +57.50% | 2.3K |
$1.94 | $4,462.00 | 6.3K |
Oct 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
∞
| 4K |
$2.05 | $8,200.00 | 4K |
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 31
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 14
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Synergy Pharmaceuticals, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +44.91% | 36.13K |
$0.50 | $25,011.50 | 116.57K |
Jul 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 16
| |||
Form 4
| +185.57% | 50K |
$0.50 | $25,000.00 | 76.94K |
Apr 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 28
| |||
Form 4
| +27.15% | 6.5K |
$3.59 | $23,335.00 | 30.44K |
May 26
| |||
Form 4
|
—
|
0
|
$5.12 | -$3,251.77 | 20.44K |
Sep 19
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 6
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| +17.12% | 3.5K |
$4.12 | $14,420.00 | 23.94K |
Jun 3
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 12
| |||
Form 4/A
|
∞
| 20.44K |
—
|
—
| 20.44K |
Jan 17
| |||
Form 4
|
∞
| 20.44K |
—
|
—
| 20.44K |
Jan 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 7
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 20
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Accustem Sciences Inc. (ACUT) Snapshot price: $0.505
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Hepion Pharmaceuticals, Inc. (HEPA) Snapshot price: $1.665
Chairman
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 18
| |||
Form 4
| +87,500.00% | 7K |
$1.53 | $10,710.00 | 7.01K |
Dec 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 24
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 19
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Apr 3
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 12
| |||
Form 4
| +218.01% | 4.39K |
$1.49 | $6,545.57 | 6.41K |
Mar 4
| |||
Form 4
|
∞
| 2.02K |
—
|
—
| 2.02K |
Feb 18
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 24
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Cardiff Oncology, Inc. (CRDF) Snapshot price: $1.72
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 9
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 10
| |||
Form 4
| +32.40% | 3K |
$10.95 | $32,850.00 | 12.26K |
Mar 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 17
| |||
Form 4
| +308.47% | 6.99K |
$1.43 | $9,999.99 | 9.26K |
May 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 20
| |||
Form 4/A
| +277.93% | 10K |
$0.80 | $8,000.00 | 13.6K |
Jun 8
| |||
Form 4
| +23.17% | 10K |
$0.80 | $8,000.00 | 53.17K |
Jun 8
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 23
| |||
Form 4
| +62.89% | 16.67K |
—
|
—
| 43.17K |
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Oct 4
| |||
Form 4
| +91.57% | 12.67K |
—
|
—
| 26.5K |
Sep 2
| |||
Form 4/A
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 2
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 4
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 17
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Dec 11
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 25
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 14
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jan 26
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||